- Home
- ONEW vs IMMP Comparison
ONEW vs IMMP Comparison
Compare ONEW & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEW
- IMMP
- Stock Information
- Founded
- ONEW 2014
- IMMP 1987
- Country
- ONEW United States
- IMMP Australia
- Employees
- ONEW N/A
- IMMP N/A
- Industry
- ONEW Auto & Home Supply Stores
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- ONEW Consumer Discretionary
- IMMP Health Care
- Exchange
- ONEW Nasdaq
- IMMP Nasdaq
- Market Cap
- ONEW 244.4M
- IMMP 244.5M
- IPO Year
- ONEW 2020
- IMMP N/A
- Fundamental
- Price
- ONEW $15.75
- IMMP $1.72
- Analyst Decision
- ONEW Buy
- IMMP Buy
- Analyst Count
- ONEW 8
- IMMP 1
- Target Price
- ONEW $19.43
- IMMP $7.00
- AVG Volume (30 Days)
- ONEW 141.7K
- IMMP 74.8K
- Earning Date
- ONEW 07-31-2025
- IMMP 02-27-2025
- Dividend Yield
- ONEW N/A
- IMMP N/A
- EPS Growth
- ONEW N/A
- IMMP N/A
- EPS
- ONEW N/A
- IMMP N/A
- Revenue
- ONEW $1,790,054,000.00
- IMMP $3,019,249.00
- Revenue This Year
- ONEW $1.37
- IMMP $50.37
- Revenue Next Year
- ONEW $3.45
- IMMP N/A
- P/E Ratio
- ONEW N/A
- IMMP N/A
- Revenue Growth
- ONEW N/A
- IMMP 24.11
- 52 Week Low
- ONEW $11.58
- IMMP $1.32
- 52 Week High
- ONEW $26.78
- IMMP $2.72
- Technical
- Relative Strength Index (RSI)
- ONEW 57.55
- IMMP 50.65
- Support Level
- ONEW $14.35
- IMMP $1.60
- Resistance Level
- ONEW $16.38
- IMMP $1.81
- Average True Range (ATR)
- ONEW 1.00
- IMMP 0.06
- MACD
- ONEW 0.08
- IMMP 0.01
- Stochastic Oscillator
- ONEW 76.80
- IMMP 52.17
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.